Company intelligence / Profile preview
Kasiak Research Pvt Ltd.
- Ownership
- Private
- Development stage
- Other
Overview
Kasiak Research Pvt Ltd. is an Indian biotech company focused on developing autologous adipose-derived adult stem cell therapies. The company has conducted at least 14 clinical trials, including a multicentric Phase I/II study evaluating the safety and efficacy of intravenous autologous adipose-derived adult stem cells for idiopathic pulmonary fibrosis. Other programs target chronic limb-threatening ischemia and potentially diabetic foot ulcers. No commercialized products are reported as of March 2025[1][5].
- Therapeutic areas
- PulmonologyCardiovascularEndocrinology
- Modalities
- Autologous adipose-derived adult stem cells[1]
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Kasiak Research Pvt Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kasiak Research Pvt Ltd..